$10B
$10B
$10B
$1B$10B
$10B
$10B
$10B
$10B
$50M$100MAchillion Pharmaceuticals, Inc. uses 8 technology products and services including CIM Technologies, Reltio, Immuta, and more. Explore Achillion Pharmaceuticals, Inc.'s tech stack below.
| Achillion Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@achillion.com | 95% |
| FirstLast@achillion.com | 4% |
| FirLast@achillion.com | 1% |
| First.Last@alexion.com | 83% |
| Last@alexion.com | 15% |
| First@alexion.com | 1% |
| First.Middle@alexion.com | 1% |
Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees
On January 28, 2020, Achillion Pharmaceuticals was acquired by Alexion Pharmaceuticals, Inc. As part of Alexion, we are continuing to advance a clinical-stage portfolio of orally administered factor D inhibitors and working toward the mission of transforming the lives of people with rare diseases.”
Company Overview
Media & News
Funding & FinancialsAchillion Pharmaceuticals, Inc. has raised a total of $51M of funding over 6 rounds. Their latest funding round was raised on Nov 15, 2017 in the amount of $51M.
Achillion Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $25M$50M
Funding & FinancialsAchillion Pharmaceuticals, Inc. has raised a total of $51M of funding over 6 rounds. Their latest funding round was raised on Nov 15, 2017 in the amount of $51M.
Achillion Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $25M$50M
1-888-653-2347 
support@leadiq.com